ARCHIVES

ACS Executive Proposes Efficiency Plan, Critics Fear Erosion Of Local Influence

This article is from The Cancer Letter archive.

Vol. 24 No. 17 | May 1, 1998

Download PDF Visit The Full Archive

Related Articles

Two Phase III Afatinib Trials Demonstrate Prolonged Survival

May 30, 2014

After Aggressive Budgetary Trimming, At $33 Million NCI’s caBIG Remains Big

December 2, 2011

Malone Retires As NIH Deputy, Raub To Succeed Him

August 22, 1986

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009

Sexual Function Affected By Stem Cell Transplant

September 28, 2007

Decision Delayed On Breast Cancer Study Until After Consensus Meeting

July 5, 1985